生物谷
(833266)
| 流通市值：6.97亿 | | | 总市值：11.23亿 |
| 流通股本：7693.51万 | | | 总股本：1.24亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 420,136,311.75 | 288,102,917.17 | 154,441,052.85 | 622,338,700.67 |
| 营业收入 | 420,136,311.75 | 288,102,917.17 | 154,441,052.85 | 622,338,700.67 |
| 二、营业总成本 | 413,228,498.54 | 276,423,111.01 | 143,357,725.12 | 600,685,735.41 |
| 营业成本 | 99,270,136.57 | 64,707,860.14 | 32,158,096.78 | 118,619,183.21 |
| 税金及附加 | 7,947,952.82 | 5,337,035.49 | 2,980,519.63 | 10,241,849.99 |
| 销售费用 | 249,985,366.04 | 172,855,093.11 | 91,884,232.81 | 394,867,241.35 |
| 管理费用 | 46,395,822.12 | 26,858,065.93 | 13,415,205.69 | 55,703,833.29 |
| 研发费用 | 9,208,001.89 | 6,111,684.85 | 2,782,072.88 | 20,130,564.61 |
| 财务费用 | 421,219.1 | 553,371.49 | 137,597.33 | 1,123,062.96 |
| 其中:利息费用 | 2,160,758.39 | 1,525,229.95 | 769,546.31 | 1,857,194.95 |
| 其中:利息收入 | 1,755,030.05 | 981,172.9 | 638,721.58 | 757,062.13 |
| 加:公允价值变动收益 | 124,026.71 | 124,026.71 | - | -2,156,773.34 |
| 加:投资收益 | 447,686.62 | 447,686.62 | - | 2,599,320.3 |
| 资产处置收益 | 79,592 | 80,079.43 | - | -193,493.87 |
| 资产减值损失(新) | -632,544.81 | -312,472.34 | -64,307.97 | -4,569,478.24 |
| 信用减值损失(新) | -8,657,613.09 | -8,662,533.23 | 839,036.56 | -42,094,753.68 |
| 其他收益 | 4,822,791.26 | 3,383,969.46 | 1,666,510.49 | 12,472,130.88 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 3,091,751.9 | 6,740,562.81 | 13,524,566.81 | -12,290,082.69 |
| 加:营业外收入 | 0.32 | 0.32 | 0.32 | 39.73 |
| 减:营业外支出 | 337,319.18 | 405,473.15 | 277,129.33 | 18,350.52 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 2,754,433.04 | 6,335,089.98 | 13,247,437.8 | -12,308,393.48 |
| 减:所得税费用 | 963,916.76 | 1,533,398.84 | 2,718,173.49 | -108,111.43 |
| 六、净利润 | 1,790,516.28 | 4,801,691.14 | 10,529,264.31 | -12,200,282.05 |
| 持续经营净利润 | 1,790,516.28 | - | 10,529,264.31 | -12,200,282.05 |
| 归属于母公司股东的净利润 | 1,790,516.28 | 4,801,691.14 | 10,529,264.31 | -12,200,282.05 |
| (一)基本每股收益 | 0.01 | 0.04 | 0.08 | -0.1 |
| (二)稀释每股收益 | 0.01 | 0.04 | - | -0.1 |
| 九、综合收益总额 | 1,790,516.28 | 4,801,691.14 | 10,529,264.31 | -12,200,282.05 |
| 归属于母公司股东的综合收益总额 | 1,790,516.28 | 4,801,691.14 | - | -12,200,282.05 |
| 公告日期 | 2024-10-29 | 2024-08-26 | 2024-04-29 | 2024-04-29 |
| 审计意见(境内) | | | | 保留意见 |